Results from a study called Mariposa found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's molecular ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

New research suggests a genetic mutation previously believed to promote esophageal cancer might actually play a protective ...

Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...